Travere Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2023
Total Assets: $788.9M
Liabilities Breakdown FY2023
Total Liabilities: $588.1M
Asset Breakdown
Total Assets: $788.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $58.2M | 7.4% |
| Accounts Receivable | $21.2M | 2.7% |
| Inventory | $9.4M | 1.2% |
| Property, Plant & Equipment | $7.5M | 0.9% |
| Goodwill | $800.0K | 0.1% |
| Intangible Assets | $104.4M | 13.2% |
| Other Assets | $587.4M | 74.5% |
Liabilities Breakdown
Total Liabilities: $588.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $41.7M | 7.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $546.4M | 92.9% |